Analytical Profile: PHARMOS, a.s.,PHOENIX lékárenský velkoobchod, s.r.o.
Key data on tenders won by this company, activity trends, and recent successes.
Tenders Won (12m)
6
Total Won Value (12m)
€849K
Average Contract Won
€141K
Top Category Won
Medical equipments, pharmaceuticals and personal care products
PHARMOS, a.s.,PHOENIX lékárenský velkoobchod, s.r.o. is a company actively participating in and winning public tenders. We present an analytical overview of their wins and contract values over the past 12 months.
According to our data, this company has won 6 tenders in the last year, with a total estimated value of €849K. The average contract value during this period was €141K, providing insight into the typical size of their successful bids.
Public Data vs. Professional Intelligence
You are viewing a free, public snapshot of this company's activity. The tend.ee Professional plan unlocks real-time data, predictive analytics, and our full AI-powered competitive analysis for this and thousands of other companies.
Recent Tenders (Sample)
| Date | Title | Status | Value (EUR) |
|---|---|---|---|
| 2025-10-22 | Czechia – Pharmaceutical products – Dynamický nákupní systém na dodávky léčivých přípravků | Tender Result | €5K |
| 2025-10-01 | Czechia – Medicinal products for functional gastrointestinal disorders – Léčivé přípravky s obsahem pantoprazolu, omeprazolu a famotidinu | Tender Result | €169K |
| 2025-09-23 | Czechia – Pharmaceutical products – Dynamický nákupní systém na dodávky léčivých přípravků | Tender Result | €95K |
| 2025-08-14 | Czechia – Antibacterials for systemic use – Antibakteriální látky pro systémové použití XXXVI. - betalaktamová ATB | Tender Result | €417K |
| 2025-08-11 | Czechia – Medicinal products for functional gastrointestinal disorders – Léčivé přípravky s obsahem pantoprazolu, omeprazolu a famotidinu | Tender Result | €157K |
Analyze with tend.ee AI Co-pilot
Consult your personalized AI Co-pilot on your winning strategy.
Access all 6 tenders from this category.
Get real-time alerts for new opportunities.
Analyze historical winners and competitors.
No card required. Limited-time offer with basic personalization.